SCHEMBL8933506

SCHEMBL8933506

C=C1NC(=O)C(c2ccc(O)c(C(C)(C)C)c2C(C)(C)C)S1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.30
▸ DDB1 Q16531 1/20 0.30
▸ CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8641079 0.73 — —
SCHEMBL4499514 0.73 CA2 (0.42) CA2DDB1CRBN
SCHEMBL8933444 0.73 — —
SCHEMBL8640500 0.71 — —
SCHEMBL7748638 0.69 — —
SCHEMBL8933639 0.69 — —
SCHEMBL8641630 0.69 HSD17B3 (0.34) —
SCHEMBL8933513 0.68 — —
SCHEMBL8933502 0.68 — —
SCHEMBL8933638 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022772-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS ELI LILLY AND COMPANY (US) 1996-08-01 — — WO disclosed
Send feedback